Table 1 Baseline characteristics after adjusting for baseline covariates
Variables | Steroids | IL6-RAs | Both | P | SMD |
|---|---|---|---|---|---|
Na | 811.6 | 596.8 | 698.9 | Â | Â |
Male | 528 (65.1) | 430 (72.1) | 433 (62) | 0.25 | 0.145 |
Age [mean (SD)] | 60.9 (14.2) | 60.6 (13.8) | 61.5 (12.8) | 0.90 | 0.042 |
Weight at admission [mean (SD)] | 91.3 (27.9) | 92.7 (26.3) | 94.5 (29.9) | 0.62 | 0.076 |
Ethnic group | 0.93 | 0.113 | |||
 Hispanic | 163 (20.1) | 128 (21.5) | 147 (21.3) |  |  |
 Non-hispanic | 385 (47.4) | 285 (47.8) | 325 (47) |  |  |
CVD | 176 (21.6) | 75 (12.6) | 161 (23) | 0.11 | 0.183 |
Asthma/COPD | 143 (17.6) | 84 (14.1) | 147 (21) | 0.33 | 0.121 |
Hydroxychloroquine | 164 (20.2) | 181 (30.2) | 180 (26) | 0.15 | 0.141 |
Azithromycin | 300 (37) | 279 (46.7) | 294 (42.1) | 0.32 | 0.122 |
Antiviral | 145 (18) | 78 (13.1) | 141 (20.2) | 0.42 | 0.136 |
ARDS grade | 0.79 | 0.148 | |||
 Mild (P:F 200–300) | 22 (2.8) | 17 (3) | 23 (3.3) |  |  |
 Moderate (P:F 100–199) | 83 (10.7) | 38 (6.5) | 41 (6) |  |  |
 Severe (P:F < 100) | 132 (16.9) | 79 (13.8) | 113 (16.2) |  |  |
Any anticoagulant | 693 (85.3) | 504 (84.4) | 560 (80.1) | 0.46 | 0.093 |
Therapeutic anticoagulation | 179 (22.1) | 87 (14.6) | 162 (23.1) | 0.15 | 0.147 |
FiO2 lowest [mean (SD)] | 0.56 (0.25) | 0.52 (0.24) | 0.57 (0.24) | 0.43 | 0.127 |
Neuromuscular blocker | 659 (82) | 520 (87) | 625 (89.4) | 0.15 | 0.16 |
Vasopressors | 638 (78.6) | 506 (84.8) | 612 (87.5) | 0.14 | 0.16 |